Jaka jest cena za Algorae Pharmaceuticals Limited (1AI)

Cena za Algorae Pharmaceuticals Limited (1AI) wynosi $0.00846342

Jaka jest kapitalizacja rynkowa dla Algorae Pharmaceuticals Limited (1AI)

Kapitalizacja rynkowa dla Algorae Pharmaceuticals Limited (1AI) wynosi $17.16M

Algorae Pharmaceuticals Limited (1AI) Podziały Akcji

Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.

Rok	Podział	Mnożnik	Skumulowany mnożnik
Za mało danych dla podanych dat.

Rok

Podział

Mnożnik

Skumulowany mnożnik

Za mało danych dla podanych dat.

Firma	Liczba podziałów akcji	Skumulowany mnożnik	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
CSL Limited CSL.AX	1	x3	AU
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR

Firma

Liczba podziałów akcji

Skumulowany mnożnik

Kraj